Dr Donna Rowen from ScHARR has been appointed as Principal investigator for the new UK EQ-5D-5L valuation study. The ScHARR team also includes Dr Clara Mukuria and Professor John Brazier. ScHARR will be collaborating with researchers from Bangor University, PHMR, Queens University Belfast, University of Leeds and University of Oxford. ScHARR is one of the collaborating sites conducting interviews.
The Principal Investigator, Donna Rowen, welcomed the appointments; “The UK research team working across 6 sites are looking forward to collaborating together to generate the much needed EQ-5D-5L value set for the UK.”
The Steering Group has representatives from National Institute for Health and Care Excellence (NICE), Department of Health and Social Care, NHS England, the EuroQol Research Foundation and academic experts. Independent Quality Control will be built in to every stage of the project. Data collection is expected to begin in early 2021.
For further details including the wider study team see:
The following is taken from the Euroqol website
NICEs current position on EQ-5D-5L: Prior to the completion and publication of the new valuation study, the interim position in England regarding the use of the EQ-5D-5L for companies, academic groups, and others preparing evidence submissions for NICE can be viewed on their website.
Steering Group: The Steering Group comprises representatives from the EuroQol Research Foundation, National Institute for Health and Care Excellence (NICE), Department of Health and Social Care, NHS England and academic experts. The list of members can be found on the Blog.
About valuation studies: The new valuation study will provide a UK value set for the EQ-5D-5L. The value set will provide values (weights) for EQ-5D-5L health state descriptions according to the preferences of the UK general population. These are used in the calculation of quality adjusted life years (QALYs) that inform economic evaluations of healthcare interventions.
About EuroQol: The EuroQol Group is committed to supporting scientific endeavours that further the measurement and valuation of health and advance the use of measures like the EQ-5D-5L to benefit patients and inform decision makers
https://euroqol.org/
